Medical News Bulletin - Daily Medical News, Health News, Clinical Trials And Clinical Research, Medical Technology, Fitness And Nutrition News–In One Place

Is body sculpting safe? While for some individuals who are properly screened, non-surgical body shaping techniques may have minimal risks of complications in the short run, that does not mean that all treatments or devices are safe. Safety is dependent upon the type of technology employed, the particular device in use, treatment parameters, the treatment […]

The post Is Non-Surgical Body Sculpting Safe? What the Research Actually Shows appeared first on Medical News Bulletin.

Medical News Bulletin - Daily Medical News, Health News, Clinical Trials And Clinical Research, Medical Technology, Fitness And Nutrition News–In One Place

Been prescribed metformin for PMOS, obesity or diabetes and planning to get pregnant? Maybe your doctor is suggesting metformin for your gestational diabetes? If so, you might be wondering whether exposure to metformin in utero is safe. The good news is that epidemiologists and paediatricians are looking into it. Researchers reported last week in the […]

The post Bulletin: Metformin, Pregnancy and Child Development appeared first on Medical News Bulletin.

Medical News Bulletin - Daily Medical News, Health News, Clinical Trials And Clinical Research, Medical Technology, Fitness And Nutrition News–In One Place

If you like research and intellectual problems challenge you, you’ll be happy to know that research-oriented career paths bring exciting benefits (after you’ve put in the work). For people who want to follow a career path that lets them make a difference on a large scale, perhaps on a global level, consider making their way […]

The post How Epidemiologists Turn Research Into Public Health Action appeared first on Medical News Bulletin.

American College of Physicians, or ACP, issued new clinical guidance in Annals of Internal Medicine, recommending hormone therapy as a first-line treatment for menopausal vasomotor symptoms.
Menopause has received increased attention in recent weeks, with a Senate committee holding the first-ever congressional hearing on the condition. During the hearing, witnesses voiced support for the FDA’s updates to hormone therapy labeling, where warnings for CVD, breast cancer and probable dementia were removed from six products following an FDA panel discussion in July 2025.
Experts previously told

ANAHEIM, Calif. — Results of a Johnson & Johnson survey presented at Academy 2026 indicate that eye care professionals could have a role in women’s health by discussing the overlap of presbyopia and perimenopause with their patients.
In a survey of 75 female eye care professionals who were asked about the link between perimenopause and presbyopia, “The main finding was that there was a gap between awareness and action,” Meredith Bishop, OD, MS, FAAO, director of global medical education at Johnson & Johnson, told Healio.
{{VIDEO}}
The survey was conducted online in December 2025 among

The CDC, WHO and other agencies said they are monitoring the situation surrounding the death of a laboratory worker in Russia who worked at an institute focused on plague research.
“We are aware of reports of a fatal case of suspected pneumonic plague in Irkutsk Oblast, Russia,” a State Department spokesman told Healio. “Many details have not been confirmed. We encourage Russian authorities to share accurate information quickly and openly.”
WHO told Healio that the lab worker died on Oct. 2 of “severe pneumonia,” but that “no cause of death has been officially confirmed, and laboratory testing

The North American Spine Society announced revised recombinant human bone morphogenetic protein-2 coverage recommendations for patients undergoing spinal fusion surgery, according to a press release.
“The new NASS recommendations support rhBMP-2 as an adjunct in posterolateral lumbar fusion and transforaminal lumbar interbody fusion specifically in adult patients at high risk for nonunion,” Mohamad Bydon, MD, cochair of the NASS coverage committee and chair of neurological surgery at the University of Chicago, told Healio.
The new guidelines follow evidence from initial FDA investigational

VIENNA — Aflibercept 0.4 mg intravitreal injection in preterm and low birthweight infants with acute-phase retinopathy of prematurity was effective and well tolerated over 5 years of follow-up in a study presented at the Euretina congress.
Based on the original FIREFLEYE study, FIREFLEYE next was the first prospective controlled phase 3b study evaluating the long-term efficacy and safety of Eylea (aflibercept 0.4 mg; Regeneron, Bayer) vs. laser photocoagulation.
“We followed all treated infants for up to 5 years and had a very good retention rate, with 98 out of 113 patients at the end of this

SAN DIEGO — AI use is growing rapidly among healthcare workers, but its adoption in pediatrics is still limited.
There are now large language models built specifically for clinicians, and many are using them despite limited data about their performance, R. Brandon Hunter, MD, FAAP, medical director of clinical AI at Texas Children’s said during a presentation at the AAP National Conference & Exhibition.
“This time is strange,” Hunter told attendees. “Normally in healthcare, we’re just so slow to adopt new technology... But my personal feeling, having interacted with it a lot, is that it’s

Are cancer centers set up to provide the high-quality survivorship care outlined in the National Standards for Cancer Survivorship Care?
A study involving 25 multidisciplinary experts at Baylor College of Medicine identified gaps in formal and consistent policies regarding survivorship care, as well as mechanisms to evaluate their impact.
“The goal is to make high-quality survivorship care routine, not exceptional,” Hoda J. Badr, PhD, J. Ewing Mears Endowed Professor and director of the division of population science at Thomas Jefferson University, told Healio.
“We have the standards. We know